Original Articles 2017

Nezu M, Souma T, Yu L, Suzuki T, Saigusa D, Ito S, Suzuki N*, Yamamoto M*.

Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression.

Kidney Int 2017 Feb;91(2):387-401. doi: 10.1016/j.kint.2016.08.023.

Press release  Press release

 

Hirano I, Suzuki N, Yamazaki S, Sekine H, Minegishi N, Shimizu R, Yamamoto M.

Renal anemia model mouse established by transgenic rescue with erythropoietin gene lacking kidney-specific regulatory elements.

Mol Cell Biol 2017 Feb 1;37(4). pii: e00451-16. doi: 10.1128/MCB.00451-16.

 

Nezu M, Souma T, Yu L, Sekine H, Takahashi N, Wei AZ, Ito S, Fukamizu A,

Zsengeller ZK, Nakamura T, Hozawa A, Karumanchi SA, Suzuki N*, Yamamoto M*

Nrf2 inactivation enhances placental angiogenesis in a preeclampsia mouse model and improves maternal and fetal outcomes.

Sci Signal. 2017 May 16;10(479). pii: eaam5711. doi: 10.1126/scisignal.aam5711.

Press release

 

 

Review Articles 2017

Suzuki N*, Gradin K, Poellinger L, Yamamoto M.

Regulation of hypoxia-inducible gene expression after HIF activation.

Exp Cell Res 2017 Mar 9. pii: S0014-4827(17)30120-9. doi: 10.1016/j.yexcr.2017.03.013. [Epub ahead of print] PubMed PMID: 28286304.

 

Nezu M, Suzuki N*, Yamamoto M.

Targeting the KEAP1-NRF2 system to prevent kidney disease progression.

Am J Nephrol 2017;45:473-483 (DOI:10.1159/000475890)